Vanguard Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.08M | Sell |
210,301
-92,252
| -30% | -$1.75M | ﹤0.01% | 3177 |
|
|
2025
Q3 | $2.35M | Sell |
302,553
-4,583
| -1% | -$34.4K | ﹤0.01% | 3528 |
|
|
2025
Q2 | $2.27M | Sell |
307,136
-27,975
| -8% | -$246K | ﹤0.01% | 3498 |
|
|
2025
Q1 | $2.88M | Buy |
335,111
+52,810
| +19% | +$815K | ﹤0.01% | 3362 |
|
|
2024
Q4 | $10.1M | Sell |
282,301
-4,797
| -2% | -$248K | ﹤0.01% | 2952 |
|
|
2024
Q3 | $13.6M | Buy |
287,098
+18,997
| +7% | +$838K | ﹤0.01% | 2802 |
|
|
2024
Q2 | $13.5M | Buy |
268,101
+17,126
| +7% | +$1.24M | ﹤0.01% | 2753 |
|
|
2024
Q1 | $28.1M | Buy |
250,975
+1,471
| +0.6% | +$146K | ﹤0.01% | 2424 |
|
|
2023
Q4 | $14.5M | Buy |
249,504
+2,059
| +0.8% | +$82.8K | ﹤0.01% | 2750 |
|
|
2023
Q3 | $7.86M | Buy |
247,445
+18,460
| +8% | +$877K | ﹤0.01% | 3024 |
|
|
2023
Q2 | $18.8M | Buy |
228,985
+43,445
| +23% | +$6.36M | ﹤0.01% | 2619 |
|
|
2023
Q1 | $19.1M | Buy |
185,540
+7,578
| +4% | +$1.06M | ﹤0.01% | 2602 |
|
|
2022
Q4 | $26.1M | Buy |
177,962
+2,842
| +2% | +$480K | ﹤0.01% | 2501 |
|
|
2022
Q3 | $29.6M | Sell |
175,120
-14,229
| -8% | -$2.31M | ﹤0.01% | 2447 |
|
|
2022
Q2 | $21.9M | Buy |
189,349
+51,938
| +38% | +$4.88M | ﹤0.01% | 2597 |
|
|
2022
Q1 | $13.7M | Sell |
137,411
-6,886
| -5% | -$804K | ﹤0.01% | 2978 |
|
|
2021
Q4 | $22.4M | Sell |
144,297
-2,967
| -2% | -$577K | ﹤0.01% | 2776 |
|
|
2021
Q3 | $34.7M | Buy |
147,264
+20,001
| +16% | +$5.84M | ﹤0.01% | 2559 |
|
|
2021
Q2 | $43.2M | Buy |
127,263
+2,568
| +2% | +$972K | ﹤0.01% | 2453 |
|
|
2021
Q1 | $50.4M | Buy |
124,695
+1,954
| +2% | +$948K | ﹤0.01% | 2312 |
|
|
2020
Q4 | $81.7M | Buy |
122,741
+9,113
| +8% | +$5.07M | ﹤0.01% | 1939 |
|
|
2020
Q3 | $52.9M | Sell |
113,628
-951
| -0.8% | -$481K | ﹤0.01% | 1993 |
|
|
2020
Q2 | $67M | Buy |
114,579
+38,898
| +51% | +$13.3M | ﹤0.01% | 1859 |
|
|
2020
Q1 | $11M | Buy |
75,681
+990
| +1% | +$173K | ﹤0.01% | 2574 |
|
|
2019
Q4 | $10.7M | Sell |
74,691
-168
| -0.2% | -$12.3K | ﹤0.01% | 2825 |
|
|
2019
Q3 | $2.96M | Sell |
74,859
-1,281
| -2% | -$93.1K | ﹤0.01% | 3315 |
|
|
2019
Q2 | $7.71M | Buy |
76,140
+16,120
| +27% | +$1.9M | ﹤0.01% | 2994 |
|
|
2019
Q1 | $7.89M | Buy |
60,020
+49,353
| +463% | +$6.21M | ﹤0.01% | 2952 |
|
|
2018
Q4 | $1.09M | Sell |
10,667
-13,377
| -56% | -$2.12M | ﹤0.01% | 3547 |
|
|
2018
Q3 | $6.01M | Buy |
24,044
+6,157
| +34% | +$2.06M | ﹤0.01% | 3158 |
|
|
2018
Q2 | $7.99M | Buy |
17,887
+1,019
| +6% | +$447K | ﹤0.01% | 3013 |
|
|
2018
Q1 | $6.65M | Buy |
16,868
+9,615
| +133% | +$3.8M | ﹤0.01% | 3025 |
|
|
2017
Q4 | $2.98M | Buy |
7,253
+916
| +14% | +$399K | ﹤0.01% | 3307 |
|
|
2017
Q3 | $2.74M | Buy |
6,337
+3,337
| +111% | +$1.32M | ﹤0.01% | 3310 |
|
|
2017
Q2 | $1.05M | Buy |
+3,000
| New | +$1.04M | ﹤0.01% | 3556 |
|
Other funds holding MRSN
NI
BCLSI
RSCM
AV
AAA
GLF